Indaptus Therapeutics Inc (INDP)

Indaptus Therapeutics Inc (INDP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $380M; returns 1 day +5.7%, 1 week +20.2%, 1 year -11.0%.

Indaptus Therapeutics Inc. (INDP) is a clinical-stage biotechnology company focused on developing novel, systemically-administered immunotherapies for cancer and viral infections.

Groups INDP belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Gram-Negative Bacteria
• Healthcare
• Life Sciences
• Cancer Therapeutics
• Infectious Diseases
• Antivirals

INDP financial model: income statement, cash flow and balance sheet